Methylene blue reversal of ifosfamide-related encephalopathy.
Raj
Ashok B
AB
Bertolone
Salvatore J
SJ
Jaffe
Norman
N
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002648:Child; D004569:Electroencephalography; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D008751:Methylene Blue / Q000627:therapeutic use*; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D012516:Osteosarcoma / Q000188:drug therapy / Q000556:secondary; D014057:Tomography, X-Ray Computed
D018906:Antineoplastic Agents, Alkylating; D004791:Enzyme Inhibitors; D008751:Methylene Blue; D007069:Ifosfamide